{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:46:48Z","timestamp":1789559208106,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T00:00:00Z","timestamp":1427328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.lungcan.2015.03.020","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T17:04:37Z","timestamp":1428771877000},"page":"304-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Prognosis in advanced lung cancer \u2013 A prospective study examining key clinicopathological factors"],"prefix":"10.1016","volume":"88","author":[{"given":"Claribel P.","family":"Simmons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippos","family":"Koinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie T.","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Fearon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tora S.","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn Henning","family":"Gronberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Gioulbasanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lungcan.2015.03.020_bib0115","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1200\/JCO.2005.11.138","article-title":"Communicating with realism and hope: incurable cancer patients\u2019 views on the disclosure of prognosis","volume":"23","author":"Hagerty","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7408","key":"10.1016\/j.lungcan.2015.03.020_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.327.7408.195","article-title":"A systematic review of physicians\u2019 survival predictions in terminally ill cancer patients","volume":"327","author":"Glare","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.lungcan.2015.03.020_bib0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JOP.2011.000374","article-title":"Focused update of 2009 American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer","volume":"8","author":"Azzoli","year":"2012","journal-title":"J Oncol Pract"},{"issue":"21","key":"10.1016\/j.lungcan.2015.03.020_bib0130","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1200\/JCO.2005.03.6236","article-title":"Why do patients choose chemotherapy near the end of life?. A review of the perspective of those facing death from cancer","volume":"24","author":"Matsuyama","year":"2006","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.lungcan.2015.03.020_bib0135","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","article-title":"Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?","volume":"90","author":"Ross","year":"2004","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2015.03.020_bib0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.lungcan.2012.04.008","article-title":"The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer","volume":"77","author":"Gioulbasanis","year":"2012","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2015.03.020_bib0145","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00520-011-1282-x","article-title":"Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis","volume":"20","author":"Giannousi","year":"2012","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2015.03.020_bib0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S0029665108007131","article-title":"An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer","volume":"67","author":"McMillan","year":"2008","journal-title":"Proc Nutr Soc"},{"issue":"Suppl. 4","key":"10.1016\/j.lungcan.2015.03.020_bib0155","doi-asserted-by":"crossref","first-page":"iv123","DOI":"10.1093\/annonc\/mdi921","article-title":"Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials","volume":"16","author":"Gebbia","year":"2005","journal-title":"Ann Oncol"},{"issue":"6 Suppl. 11","key":"10.1016\/j.lungcan.2015.03.020_bib0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.seminoncol.2004.10.006","article-title":"Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status","volume":"31","author":"Govindan","year":"2004","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.lungcan.2015.03.020_bib0165","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.lungcan.2015.03.020_bib0170","doi-asserted-by":"crossref","first-page":"e1001216","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.lungcan.2015.03.020_bib0175","first-page":"424","article-title":"Prognostic value of laboratory factors of performance status in lung cancer patients","volume":"66","author":"Wojcik","year":"2009","journal-title":"Przegl Lek"},{"issue":"1","key":"10.1016\/j.lungcan.2015.03.020_bib0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10637-007-9088-x","article-title":"Prognostic factors among cancer patients with good performance status screened for phase I trials","volume":"26","author":"Penel","year":"2008","journal-title":"Invest New Drugs"},{"issue":"11","key":"10.1016\/j.lungcan.2015.03.020_bib0185","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1054\/bjoc.2001.2162","article-title":"Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer","volume":"85","author":"Ando","year":"2001","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2015.03.020_bib0190","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/JTO.0b013e318186a272","article-title":"Should patient-rated performance status affect treatment decisions in advanced lung cancer?","volume":"3","author":"Dajczman","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.lungcan.2015.03.020_bib0195","first-page":"209","article-title":"How accurate are physicians\u2019 clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients?. A systematic review","volume":"13","author":"Chow","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"6","key":"10.1016\/j.lungcan.2015.03.020_bib0200","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/sj.bjc.6601231","article-title":"Performance status score: do patients and their oncologists agree?","volume":"89","author":"Blagden","year":"2003","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2015.03.020_bib0205","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/bjc.1993.140","article-title":"Performance status assessment in cancer patients. An inter-observer variability study","volume":"67","author":"Sorensen","year":"1993","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2015.03.020_bib0210","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"19","key":"10.1016\/j.lungcan.2015.03.020_bib0215","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","article-title":"Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system","volume":"19","author":"Laird","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2015.03.020_bib0220","first-page":"1","article-title":"Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway","author":"Anshushaug","year":"2014","journal-title":"Acta Oncol"}],"updated-by":[{"DOI":"10.1016\/j.lungcan.2017.04.015","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000}}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215001725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215001725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T05:40:20Z","timestamp":1566538820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500215001725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0169500215001725"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.03.020","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725433971.793507015","asserted-by":"object"}]},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosis in advanced lung cancer \u2013 A prospective study examining key clinicopathological factors","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}